China Proposes Many New GLP Provisions For Pharma
Pharmaceutical companies are being advised to comment on and monitor the revised good laboratory practices that the China Food and Drug Administration has issued for consultation.
You may also be interested in...
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
New medicines under evaluation at the European Medicines Agency.
The European Medicine Agency has recommended extending the therapeutic indication of a raft of drugs that are already authorized in the EU.